{
    "medicine_id": "e773baee973fb0fbb754ffbc7a6e132e2c23bcaf",
    "platform_id": "DB04900",
    "metadata": {
        "name": "Natrecor 1 5 mg 5mL Injection powder lyophilized for solution",
        "composition": "1 5 mg 5mL Thymalfasin",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate antibody titers from previous immunization",
            "contraindications": {
                "disease": "There are no reported instances of deliberate or accidental overdosage in humans Animal toxicology studies have shown no adverse reactions in single doses up to 20 mg kg and in repeated doses up to 6 mg kg day for 13 weeks which were the highest doses studied The highest single dose tested in animals represents 800 times the clinical dose",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Thymalfasin is a 28 amino acid polypeptide produced synthetically but originally isolated from thymosin fraction 5 a bovine thymus extract containing a number of immunologically active peptides In vitro studies have shown that Thymalfasin can influence T cell production and maturation stimulate production of Th1 cytokines such as interferon gamma and interleukin 2 and activate natural killer cell mediated cytotoxicity",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Thymalfasin"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thymalfasin"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Thymalfasin"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Thymalfasin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}